GSK reports positive data from trial of endometrial cancer drug

GlaxoSmithKline said on Tuesday a study testing its experimental drug dostarlimab in women with recurrent or advanced endometrial cancer showed promising results.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news